AbbVie, Inc. (ABBV)
210.39
-0.38
(-0.18%)
USD |
NYSE |
May 15, 16:00
210.63
+0.24
(+0.11%)
After-Hours: 20:00
AbbVie Total Assets (Quarterly) : 136.46B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Amgen, Inc. | 92.50B |
| Biogen, Inc. | 29.48B |
| Gilead Sciences, Inc. | 56.28B |
| Regeneron Pharmaceuticals, Inc. | 40.87B |
| Moderna, Inc. | 11.49B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 143.08B |
| Shareholders Equity (Quarterly) | -6.656B |
| Debt to Equity Ratio | -10.95 |
| Current Ratio | 0.7964 |
| Net Debt Paydown Yield | -0.26% |